European Union - English - EMA (European Medicines Agency)

apotex europe bv - olanzapine - schizophrenia; bipolar disorder - psycholeptics - olanzapine is indicated for the treatment of schizophrenia.olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.olanzapine is indicated for the treatment of moderate to severe manic episode.in patients whose manic episode has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - pantoprazole sodium sesquihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - pantoprazole sodium sesquihydrate -

Ireland - English - HPRA (Health Products Regulatory Authority)

apotex europe b.v. - voriconazole - film coated tablet - 50 milligram - voriconazole - antimycotics for systemic use, triazole derivatives - voriconazole, is a broad spectrum, triazole antifungal agent and is indicated in adults and children aged 2 years and above as follows: treatment of invasive aspergillosis. treatment of candidemia in non-neutropenic patients. treatment of fluconazole-resistant serious invasive candida infections (including c. krusei). treatment of serious fungal infections caused by scedosporium spp. and fusarium spp. voriconazole apotex should be administered primarily to patients with progressive, possibly life-threatening infections. prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (hsct) recipients

Ireland - English - HPRA (Health Products Regulatory Authority)

apotex europe b.v. - voriconazole - film coated tablet - 200 milligram - voriconazole - antimycotics for systemic use, triazole derivatives - voriconazole, is a broad spectrum, triazole antifungal agent and is indicated in adults and children aged 2 years and above as follows: treatment of invasive aspergillosis. treatment of candidemia in non-neutropenic patients. treatment of fluconazole-resistant serious invasive candida infections (including c. krusei). treatment of serious fungal infections caused by scedosporium spp. and fusarium spp. voriconazole apotex should be administered primarily to patients with progressive, possibly life-threatening infections. prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (hsct) recipients

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apotex sa-nv - acetylcysteine 600 mg - effervescent tablet - 600 mg - acetylcysteine 600 mg - acetylcysteine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apotex sa-nv - acetylcysteine 600 mg - granules for oral solution - 600 mg - acetylcysteine 600 mg - acetylcysteine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apotex sa-nv - beclometasone dipropionate 50 µg/dose - nasal spray, suspension - 0,05 % - beclometasone dipropionate 50 µg/dose - beclometasone

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apotex sa-nv - betahistine dihydrochloride 16 mg - tablet - 16 mg - betahistine dihydrochloride 16 mg - betahistine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apotex sa-nv - betahistine dihydrochloride 8 mg - tablet - 8 mg - betahistine dihydrochloride 8 mg - betahistine